PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans
PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans(520 views) Cervenka S, Varrone A, Fransen E, Halldin C, Farde L
Department of Clinical Neuroscience, Stockholm Brain Institute, Karolinska Institute, Stockholm, Sweden
School of Computer Science and Communication, Stockholm Brain Institute, Royal Institute of Technology, Stockholm, Sweden
References: Aalto, S., Bruck, A., Laine, M., Nagren, K., Rinne, J.O., Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: A positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457 (2005) J Neurosci, 25, pp. 2471-247
Aalto, S., Hirvonen, J., Kaasinen, V., Hagelberg, N., Kajander, J., Nagren, K., Seppala, T., Hietala, J., The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: A randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects (2009) Eur J Nucl Med Mol Imaging, 36, pp. 475-483
Abi-Dargham, A., Mawlawi, O., Lombardo, I., Gil, R., Martinez, D., Huang, Y., Hwang, D.R., Laruelle, M., Prefrontal dopamine D1 receptors and working memory in schizophrenia (2002) J Neurosci, 22, pp. 3708-3719
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L.S., Weiss, R., Laruelle, M., Increased baseline occupancy of D2 receptors by dopamine in schizophrenia (2000) Proc Natl Acad Sci USA, 97, pp. 8104-8109
Ahmad, R., Hirani, E., Grasby, P.M., Hume, S.P., Effect of reduction in endogenous dopamine on extrastriatal binding of [11C]FLB 457 in rat brain - An ex vivo study (2006) Synapse, 59, pp. 162-172
Asselin, M.C., Montgomery, A.J., Grasby, P.M., Hume, S.P., Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: Re-evaluation of the validity of zusing a cerebellar reference region (2006) J Cereb Blood Flow Metab, 27, pp. 378-392
Bose, S.K., Turkheimer, F.E., Howes, O.D., Mehta, M.A., Cunliffe, R., Stokes, P.R., Grasby, P.M., Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging (2008) Schizophr Res, 106 (2-3), pp. 148-155
Cervenka, S., Palhagen, S.E., Comley, R.A., Panagiotidis, G., Cselenyi, Z., Matthews, J.C., Lai, R.Y., Farde, L., Support for dopaminergic hypoactivity in restless legs syndrome: A PET study on D2-receptor binding (2006) Brain, 129 (PART 8), pp. 2017-2028
Cropley, V.L., Fujita, M., Innis, R.B., Nathan, P.J., Molecular imaging of the dopaminergic system and its association with human cognitive function (2006) Biol Psychiatry, 59, pp. 898-907
Cselenyi, Z., Olsson, H., Farde, L., Gulyas, B., Wavelet-aided parametric mapping of cerebral dopamine D2 receptors using the high affinity PET radioligand [11C]FLB 457 (2002) Neuroimage, 17, pp. 47-60
De La Fuente-Fernandez, R., Ruth, T.J., Sossi, V., Schulzer, M., Calne, D.B., Stoessl, A.J., Expectation and dopamine release: Mechanism of the placebo effect in Parkinson's disease (2001) Science, 293, pp. 1164-1166
Depue, R.A., Luciana, M., Arbisi, P., Collins, P., Leon, A., Dopamine and the structure of personality: Relation of agonist-induced dopamine activity to positive emotionality (1994) J Pers Soc Psychol, 67, pp. 485-498
Farde, L., Ehrin, E., Eriksson, L., Greitz, T., Hall, H., Hedstrom, C.G., Litton, J.E., Sedvall, G., Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography (1985) Proc Natl Acad Sci USA, 82, pp. 3863-3867
Farde, L., Gustavsson, J.P., Jonsson, E., D2 dopamine receptors and personality traits (1997) Nature, 385, p. 590
Farde, L., Hall, H., Ehrin, E., Sedvall, G., Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET (1986) Science, 231, pp. 258-261
Farde, L., Suhara, T., Nyberg, S., Karlsson, P., Nakashima, Y., Hietala, J., Halldin, C., A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients (1997) Psychopharmacology, 133, pp. 396-404. , Berl
Garcia-Cabezas, M.A., Rico, B., Sanchez-Gonzalez, M.A., Cavada, C., Distribution of the dopamine innervation in the macaque and human thalamus (2007) Neuroimage, 34, pp. 965-984
Garnett, E.S., Firnau, G., Nahmias, C., Dopamine visualized in the basal ganglia in living man (1983) Nature, 305 (5930), pp. 137-138
Gurevich, E.V., Joyce, J.N., Distribution of dopamine D3 receptor expressing neurons in the human forebrain comparison with D2 receptor expressing neurons (1999) Neuropsychopharmacology, 20 (1), pp. 60-80. , DOI 10.1016/S0893-133X(98)00066-9, PII S0893133X98000669
Hall, H., Farde, L., Halldin, C., Hurd, Y.L., Pauli, S., Sedvall, G., Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride (1996) Synapse, 23, pp. 115-123
Hall, H., Halldin, C., Dijkstra, D., Wikstrom, H., Wise, L.D., Pugsley, T.A., Sokoloff, P., Sedvall, G., Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907 (1996) Psychopharmacology, 128, pp. 240-247. , Berl
Halldin, C., Erixon-Lindroth, N., Pauli, S., Chou, Y.-H., Okubo, Y., Karlsson, P., Lundkvist, C., Farde, L., [11C]PE21: A highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain (2003) European Journal of Nuclear Medicine and Molecular Imaging, 30 (9), pp. 1220-1230. , DOI 10.1007/s00259-003-1212-3
Halldin, C., Foged, C., Chou, Y.-H., Karlsson, P., Swahn, C.-G., Sandell, J., Sedvall, G., Farde, L., Carbon-11-NNC 112: A radioligand for PET examination of striatal and neocortical D1-dopamine receptors (1998) Journal of Nuclear Medicine, 39 (12), pp. 2061-2068
Hietala, J., Nagren, K., Lehikoinen, P., Ruotsalainen, U., Syvalahti, E., Measurement of striatal D2 dopamine receptor density and affinity with [11C]-Raclopride in vivo: A test-retest analysis (1999) Journal of Cerebral Blood Flow and Metabolism, 19 (2), pp. 210-217
Hirvonen, J., Aalto, S., Lumme, V., Nagren, K., Kajander, J., Vilkman, H., Hagelberg, N., Hietala, J., Measurement of striatal and thalamic dopamine D2 receptor binding with11C-raclopride (2003) Nuclear Medicine Communications, 24 (12), pp. 1207-1214. , DOI 10.1097/00006231-200312000-00002
Hirvonen, M., Laakso, A., Nagren, K., Rinne, J.O., Pohjalainen, T., Hietala, J., C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo [1] (2004) Molecular Psychiatry, 9 (12), pp. 1060-1061. , DOI 10.1038/sj.mp.4001561
Hirvonen, J., Van Erp, T.G., Huttunen, J., Aalto, S., Nagren, K., Huttunen, M., Lonnqvist, J., Cannon, T.D., Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia (2005) Arch Gen Psychiatry, 62, pp. 371-378
Hirvonen, M.M., Lumme, V., Hirvonen, J., Pesonen, U., Nagren, K., Vahlberg, T., Scheinin, H., Hietala, J., C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo (2009) Prog Neuropsychopharmacol Biol Psychiatry, 33, pp. 630-636
Hultsch, D.F., MacDonald, S.W., Dixon, R.A., Variability in reaction time performance of younger and older adults (2002) J Gerontol B Psychol Sci Soc Sci, 57, pp. P101-P115
Innis, R.B., Cunningham, V.J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R.N., Holden, J., Carson, R.E., Consensus nomenclature for in vivo imaging of reversibly binding radioligands (2007) J Cereb Blood Flow Metab, 27, pp. 1533-1539
Jönsson, E.G., Nothen, M.M., Grunhage, F., Farde, L., Nakashima, Y., Propping, P., Sedvall, G.C., Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers (1999) Mol Psychiatry, 4, pp. 290-296
Kessler, R.M., Whetsell, W.O., Ansari, M.S., Votaw, J.R., De Paulis, T., Clanton, J.A., Schmidt, D.E., Manning, R.G., Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride (1993) Brain Res, 609 (1-2), pp. 237-243
Koepp, M.J., Gunn, R.N., Lawrence, A.D., Cunningham, V.J., Dagher, A., Jones, T., Brooks, D.J., Grasby, P.M., Evidence for striatal dopamine release during a video game (1998) Nature, 393, pp. 266-268
Kohler, C., Hall, H., Ogren, S.O., Gawell, L., Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain (1985) Biochem Pharmacol, 34, pp. 2251-2259
Lammertsma, A.A., Hume, S.P., Simplified reference tissue model for PET receptor studies (1996) Neuroimage, 4 (PART 1), pp. 153-158
Langer, O., Någren, K., Dolle, F., Lundkvist, C., Sandell, J., Swahn, C.G., Vaufrey, F., Halldin, C., Precursor synthesis and radiolabelling of the dopamine D2 receptor ligand [11C]raclopride from [11]methyl triflate (1999) J Labelled Comp Radiopharm, 42, pp. 1183-1193
Le Moal, M., Simon, H., Mesocorticolimbic dopaminergic network: Functional and regulatory roles (1991) Physiol Rev, 71, pp. 155-234
Logan, J., Fowler, J.S., Volkow, N.D., Wang, G.J., Ding, Y.S., Alexoff, D.L., Distribution volume ratios without blood sampling from graphical analysis of PET data (1996) J Cereb Blood Flow Metab, 16, pp. 834-840
Maldjian, J.A., Laurienti, P.J., Kraft, R.A., Burdette, J.H., An automated method for neuroanatomic and cytoarchitectonic atlasbased interrogation of fMRI data sets (2003) Neuroimage, 19, pp. 1233-1239
Malmberg, A., Jackson, D.M., Eriksson, A., Mohell, N., Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors (1993) Mol Pharmacol, 43, pp. 749-754
Mawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.R., Huang, Y., Laruelle, M., Imaging human mesolimbic dopamine transmission with positron emission tomography. I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum (2001) J Cereb Blood Flow Metab, 21, pp. 1034-1057
Monchi, O., Ko, J.H., Strafella, A.P., Striatal dopamine release during performance of executive functions: A [(11)C] raclopride PET study (2006) Neuroimage, 33, pp. 907-912
Narendran, R., Frankle, W.G., Mason, N.S., Rabiner, E.A., Gunn, R.N., Searle, G.E., Vora, S., Laruelle, M., Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: A comparative evaluation of the high af.nity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride (2009) Synapse, 63, pp. 447-461
Nyberg, S., Nilsson, U., Okubo, Y., Halldin, C., Farde, L., Implications of brain imaging for the management of schizophrenia (1998) International Clinical Psychopharmacology, 13 (SUPPL. 3), pp. S15-S20
Olsson, H., Halldin, C., Farde, L., Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET (2004) Neuroimage, 22, pp. 794-803
Pohjalainen, T., Rinne, J.O., Nagren, K., Lehikoinen, P., Anttila, K., Syvalahti, E.K., Hietala, J., The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers (1998) Mol Psychiatry, 3, pp. 256-260
Pruessner, J.C., Li, L.M., Serles, W., Pruessner, M., Collins, D.L., Kabani, N., Lupien, S., Evans, A.C., Volumetry of hippocampus and amygdala with high-resolution MRI and three-dimensional analysis software: Minimizing the discrepancies between laboratories (2000) Cereb Cortex, 10, pp. 433-442
Roland, P.E., Graufelds, C.J., Wåhlin, J., Ingelman, L., Andersson, M., Ledberg, A., Pedersen, J., Zilles, K., Human brain atlas for high resolution functional and anatomical mapping (1994) Hum Brain Mapp, 1, pp. 173-184
Sandell, J., Langer, O., Larsen, P., Dolle, F., Vaufrey, F., Demphel, S., Crouzel, C., Halldin, C., Improved specific radioactivity of the PET radioligand [11C]FLB 457 by use of the GE Medical Systems PETtrace MeI MicroLab (2000) J Labelled Comp Radiopharm, 43, pp. 331-338
Stark, D., Piel, M., Hubner, H., Gmeiner, P., Grunder, G., Rosch, F., In vitro affinities of various halogenated benzamide derivatives as potential radioligands for non-invasive quantification of D(2)-like dopamine receptors (2007) Bioorg Med Chem, 15, pp. 6819-6829
Sudo, Y., Suhara, T., Inoue, M., Ito, H., Suzuki, K., Saijo, T., Halldin, C., Farde, L., Reproducibility of [11 C]FLB 457 binding in extrastriatal regions (2001) Nucl Med Commun, 22, pp. 1215-1221
Suhara, T., Yasuno, F., Sudo, Y., Yamamoto, M., Inoue, M., Okubo, Y., Suzuki, K., Dopamine D2 receptors in the insular cortex and the personality trait of novelty seeking (2001) Neuroimage, 13, pp. 891-895
Ungerstedt, U., Stereotaxic mapping of the monoamine pathways in the rat brain (1971) Acta Physiol Scand Suppl, 367, pp. 1-48
Vilkman, H., Kajander, J., Nagren, K., Oikonen, V., Syvalahti, E., Hietala, J., Measurement of extrastriatal D2-like receptor binding with [11C]FLB 457 - A test-retest analysis (2000) Eur J Nucl Med, 27, pp. 1666-1673
Asselin, M. C., Montgomery, A. J., Grasby, P. M., Hume, S. P., Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C] FLB 457: Re-evaluation of the validity of zusing a cerebellar reference region (2006) J Cereb Blood Flow Metab, 27, pp. 378-392
Bose, S. K., Turkheimer, F. E., Howes, O. D., Mehta, M. A., Cunliffe, R., Stokes, P. R., Grasby, P. M., Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging (2008) Schizophr Res, 106 (2-3), pp. 148-155
Cropley, V. L., Fujita, M., Innis, R. B., Nathan, P. J., Molecular imaging of the dopaminergic system and its association with human cognitive function (2006) Biol Psychiatry, 59, pp. 898-907
Depue, R. A., Luciana, M., Arbisi, P., Collins, P., Leon, A., Dopamine and the structure of personality: Relation of agonist-induced dopamine activity to positive emotionality (1994) J Pers Soc Psychol, 67, pp. 485-498
Garcia-Cabezas, M. A., Rico, B., Sanchez-Gonzalez, M. A., Cavada, C., Distribution of the dopamine innervation in the macaque and human thalamus (2007) Neuroimage, 34, pp. 965-984
Garnett, E. S., Firnau, G., Nahmias, C., Dopamine visualized in the basal ganglia in living man (1983) Nature, 305 (5930), pp. 137-138
Gurevich, E. V., Joyce, J. N., Distribution of dopamine D3 receptor expressing neurons in the human forebrain comparison with D2 receptor expressing neurons (1999) Neuropsychopharmacology, 20 (1), pp. 60-80. , DOI 10. 1016/S0893-133X (98) 00066-9, PII S0893133X98000669
Hirvonen, M. M., Lumme, V., Hirvonen, J., Pesonen, U., Nagren, K., Vahlberg, T., Scheinin, H., Hietala, J., C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo (2009) Prog Neuropsychopharmacol Biol Psychiatry, 33, pp. 630-636
Hultsch, D. F., MacDonald, S. W., Dixon, R. A., Variability in reaction time performance of younger and older adults (2002) J Gerontol B Psychol Sci Soc Sci, 57, pp. P101-P115
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Carson, R. E., Consensus nomenclature for in vivo imaging of reversibly binding radioligands (2007) J Cereb Blood Flow Metab, 27, pp. 1533-1539
J nsson, E. G., Nothen, M. M., Grunhage, F., Farde, L., Nakashima, Y., Propping, P., Sedvall, G. C., Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers (1999) Mol Psychiatry, 4, pp. 290-296
Kessler, R. M., Whetsell, W. O., Ansari, M. S., Votaw, J. R., De Paulis, T., Clanton, J. A., Schmidt, D. E., Manning, R. G., Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I] epidepride (1993) Brain Res, 609 (1-2), pp. 237-243
Koepp, M. J., Gunn, R. N., Lawrence, A. D., Cunningham, V. J., Dagher, A., Jones, T., Brooks, D. J., Grasby, P. M., Evidence for striatal dopamine release during a video game (1998) Nature, 393, pp. 266-268
Lammertsma, A. A., Hume, S. P., Simplified reference tissue model for PET receptor studies (1996) Neuroimage, 4 (PART 1), pp. 153-158
Langer, O., N gren, K., Dolle, F., Lundkvist, C., Sandell, J., Swahn, C. G., Vaufrey, F., Halldin, C., Precursor synthesis and radiolabelling of the dopamine D2 receptor ligand [11C] raclopride from [11] methyl triflate (1999) J Labelled Comp Radiopharm, 42, pp. 1183-1193
Maldjian, J. A., Laurienti, P. J., Kraft, R. A., Burdette, J. H., An automated method for neuroanatomic and cytoarchitectonic atlasbased interrogation of fMRI data sets (2003) Neuroimage, 19, pp. 1233-1239
Monchi, O., Ko, J. H., Strafella, A. P., Striatal dopamine release during performance of executive functions: A [(11) C] raclopride PET study (2006) Neuroimage, 33, pp. 907-912
Pruessner, J. C., Li, L. M., Serles, W., Pruessner, M., Collins, D. L., Kabani, N., Lupien, S., Evans, A. C., Volumetry of hippocampus and amygdala with high-resolution MRI and three-dimensional analysis software: Minimizing the discrepancies between laboratories (2000) Cereb Cortex, 10, pp. 433-442
Roland, P. E., Graufelds, C. J., W hlin, J., Ingelman, L., Andersson, M., Ledberg, A., Pedersen, J., Zilles, K., Human brain atlas for high resolution functional and anatomical mapping (1994) Hum Brain Mapp, 1, pp. 173-184
PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans
PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans
PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans